LEADER 00000cam a2200733 i 4500
001 on1176508427
003 OCoLC
005 20210702123630.8
006 m o d
007 cr cn|||||||||
008 200602s2020 dcua obt 100 0 eng
016 7 101768370|2DNLM
019 1153273035|a1153776836|a1229743809
020 0309664063|q(electronic book)
020 9780309664066|q(electronic book)
020 |z9780309663496
020 |z0309663490
035 (OCoLC)1176508427|z(OCoLC)1153273035|z(OCoLC)1153776836
|z(OCoLC)1229743809
040 NLM|beng|erda|epn|cNLM|dOCLCO|dCUS|dEBLCP|dN$T|dUKAHL
|dYDXIT|dOCLCF|dYDX|dLVT|dOCLCO|dOCLCQ|dOCLCA
042 pcc
049 RIDW
050 4 Q180.55.S7|bE543 2020
082 04 610.72|223
090 Q180.55.S7|bE543 2020
100 1 Wizemann, Theresa M.,|0https://id.loc.gov/authorities/
names/n2001128020|erapporteurs.
245 10 Enhancing scientific reproducibility in biomedical
research through transparent reporting :|bproceedings of a
workshop /|cTheresa Wizemann, Sylvia Ncha, Amanda Wagner
Gee, and Carolyn Shore, rapporteurs ; Forum on Drug
Discovery, Development, and Translation, Forum on
Neuroscience and Nervous System Disorders, National Cancer
Policy Forum, Roundtable on Genomics and Precision Health,
Board on Health Sciences Policy, Board on Health Care
Services, Health and Medicine Division, National Academies
of Sciences, Engineering, and Medicine.
264 1 Washington, DC :|bNational Academies Press,|c[2020]
300 1 online resource (1 PDF file (xxi, 120 pages)) :
|billustrations
336 text|btxt|2rdacontent
337 computer|bc|2rdamedia
338 online resource|bcr|2rdacarrier
340 |gpolychrome|2rdacc
347 text file|2rdaft
504 Includes bibliographical references.
520 3 Sharing knowledge is what drives scientific progress --
each new advance or innovation in biomedical research
builds on previous observations. However, for experimental
findings to be broadly accepted as credible by the
scientific community, they must be verified by other
researchers. An essential step is for researchers to
report their findings in a manner that is understandable
to others in the scientific community and provide
sufficient information for others to validate the original
results and build on them. In recent years, concern has
been growing over a number of studies that have failed to
replicate previous results and evidence from larger meta-
analyses, which have pointed to the lack of
reproducibility in biomedical research. On September 25
and 26, 2019, the National Academies of Science,
Engineering, and Medicine hosted a public workshop in
Washington, DC, to discuss the current state of
transparency in the reporting of preclinical biomedical
research and to explore opportunities for harmonizing
reporting guidelines across journals and funding agencies.
Convened jointly by the Forum on Drug Discovery,
Development, and Translation; the Forum on Neuroscience
and Nervous System Disorders; the National Cancer Policy
Forum; and the Roundtable on Genomics and Precision Health,
the workshop primarily focused on transparent reporting in
preclinical research, but also considered lessons learned
and best practices from clinical research reporting. This
publication summarizes the presentation and discussion of
the workshop.
536 This activity was supported by contracts between the
National Academy of Sciences and AbbVie Inc.; Amgen Inc.
(Contract No. GHCCOPS-CSARF-175837); Association of
American Medical Colleges; AstraZeneca; Burroughs Wellcome
Fund (Contract No. 1020264); Cell Press; Critical Path
Institute; Eli Lilly and Company; FasterCures; Foundation
for the National Institutes of Health; Friends of Cancer
Research; GlaxoSmithKline (Contract No. 016084); Johnson &
Johnson; The Lancet; Merck & Co., Inc. (Contract Nos. CMO-
180308-002499 and MRL-CPO-18-2641); National Institutes of
Health (Contract No. HHSN2632018000029I; Task Order Nos.
HHSN26300007 and HHSN26300009): National Cancer Institute,
National Center for Advancing Translational Sciences,
National Institute of Allergy and Infectious Diseases,
National Institute of Mental Health, National Institute of
Neurological Disorders and Stroke, Office of Extramural
Research, Office of Science Policy; Nature Research; New
England Journal of Medicine; Sanofi (Contract No.
44723099); Takeda Pharmaceuticals (Contract No. 398929);
and U.S. Food and Drug Administration (Grant Nos.
5R13FD005496-04 and 5R13FD005496-05): Center for Drug
Evaluation and Research and Office of the Commissioner.
Any opinions, findings, conclusions, or recommendations
expressed in this publication do not necessarily reflect
the views of any organization or agency that provided
support for the project.
588 0 Online resource; title from PDF title page (viewed July 17,
2020).
590 eBooks on EBSCOhost|bEBSCO eBook Subscription Academic
Collection - North America
650 0 Medicine|xResearch.|0https://id.loc.gov/authorities/
subjects/sh85083097
650 0 Reproducible research.|0https://id.loc.gov/authorities/
subjects/sh2013002574
650 7 Medicine|xResearch.|2fast|0https://id.worldcat.org/fast/
1015059
650 7 Reproducible research.|2fast|0https://id.worldcat.org/fast
/1904473
655 2 Congress.|0https://id.nlm.nih.gov/mesh/D016423
655 7 Technical reports.|2lcgft|0https://id.loc.gov/authorities/
genreForms/gf2015026093
655 7 Technical reports.|2fast|0https://id.worldcat.org/fast/
1941336
655 7 Conference papers and proceedings.|2lcgft|0https://
id.loc.gov/authorities/genreForms/gf2014026068
655 7 Conference papers and proceedings.|2fast|0https://
id.worldcat.org/fast/1423772
700 1 Ncha, Sylvia,|0https://id.loc.gov/authorities/names/
n2019183108|erapporteurs.
700 1 Gee, Amanda Wagner,|0https://id.loc.gov/authorities/names/
no2008155685|erapporteurs.
700 1 Shore, Carolyn,|0https://id.loc.gov/authorities/names/
n2019182978|erapporteurs.
710 2 National Academies of Sciences, Engineering, and Medicine
(U.S.).|bForum on Drug Discovery, Development, and
Translation,|0https://id.loc.gov/authorities/names/
n2016189921|eissuing body.
710 2 National Academies of Sciences, Engineering, and Medicine
(U.S.).|bForum on Neuroscience and Nervous System
Disorders,|0https://id.loc.gov/authorities/names/
n2017180200|eissuing body.
710 2 National Cancer Policy Forum (U.S.),|0https://id.loc.gov/
authorities/names/n2006183479|eissuing body.
710 2 National Academies of Sciences, Engineering, and Medicine
(U.S.).|bRoundtable on Genomics and Precision Health,
|0https://id.loc.gov/authorities/names/n2016191069
|eissuing body.
711 2 Enhancing Scientific Reproducibility in Biomedical
Research Through Transparent Reporting (Workshop)|d(2019 :
|cWashington, D.C.)|0https://id.loc.gov/authorities/names/
n2020184462
776 08 |iPrint version:|aNational Academies of Sciences,
Engineering, and Medicine.|tEnhancing Scientific
Reproducibility in Biomedical Research Through Transparent
Reporting : Proceedings of a Workshop.|dWashington, D.C. :
National Academies Press, ©2020
830 0 Online access: NCBI NCBI Bookshelf.
856 40 |uhttps://rider.idm.oclc.org/login?url=https://
search.ebscohost.com/login.aspx?direct=true&scope=site&
db=nlebk&AN=2490665|zOnline ebook via EBSCO. Access
restricted to current Rider University students, faculty,
and staff.
856 42 |3Instructions for reading/downloading the EBSCO version
of this ebook|uhttp://guides.rider.edu/ebooks/ebsco
901 MARCIVE 20231220
948 |d20210708|cEBSCO|tEBSCOebooksacademic NEW 5016 |lridw
994 92|bRID
